| Reference | Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41). Oncologist. 2015 Oct;20(10):1149-53. doi: 10.1634/theoncologist.2015-0180. Epub 2015 Aug 12. Link PDF (1MB) |
| Author(s) | Jackson AE, Mian M, Kalpadakis C, Pangalis GA, Stathis A, Porro E, Conconi A, Cortelazzo S, Gaidano G, Lopez Guillermo A, Johnson PW, Martelli M, Martinelli G, Thieblemont C, McPhail ED, Copie-Bergman C, Pileri SA, Jack A, Campo E, Mazzucchelli L, Ristow K, Habermann TM, Cavalli F, Nowakowski GS, Zucca E. |
| Study | IELSG41 |
| |
| Reference | Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma. Blood 2015 Aug 20;126(8):950-6. Link PDF (764K) |
| Author(s) | Ceriani L, Martelli M, Zinzani PL, Ferreri AJ, Botto B, Stelitano C, Gotti M, Cabras MG, Rigacci L, Gargantini L, Merli F, Pinotti G, Mannina D, Luminari S, Stathis A, Russo E, Cavalli F, Giovanella L, Johnson PW, Zucca E. |
| Study | IELSG26 |
| |
| Reference | Primary and secondary bone lymphomas. Cancer Treatment Reviews. 2015. 41:235-246. Link |
| Author(s) | Messina C, Christie D, Zucca E. Gospodarowicz Mary, Ferreri AJM. |
| Study | IELSG14 |
| |
| Reference | Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group. Br J Haematol. 2014 Jul;166(1):69-76. Link |
| Author(s) | Conconi A, Raderer M, Franceschetti S, Devizzi L, Ferreri AJ, Magagnoli M, Arcaini L, Zinzani PL, Martinelli G, Vitolo U, Kiesewetter B, Porro E, Stathis A, Gaidano G, Cavalli F, Zucca E. |
| Study | IELSG34 |
| |
| Reference | [18F]Fluorodeoxyglucose Positron Emission Tomography Predicts Survival After Chemoimmunotherapy for Primary Mediastinal Large B-Cell Lymphoma: Results of the International Extranodal Lymphoma Study Group IELSG-26 Study. J Clin Oncol. 2014 Jun 10;32(17):1769-75. Link PDF (235K) |
| Author(s) | Martelli M, Ceriani L, Zucca E, Zinzani PL, Ferreri AJ, Vitolo U, Stelitano C, Brusamolino E, Cabras MG, Rigacci L, Balzarotti M, Salvi F, Montoto S, Lopez-Guillermo A, Finolezzi E, Pileri SA, Davies A, Cavalli F, Giovanella L, Johnson PW. |
| Study | IELSG26 |
| |
| Reference | Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study). Oncologist. 2014 Mar;19(3):291-8 Link PDF (1.1MB) |
| Author(s) | Bruno Ventre M, Ferreri AJ, Gospodarowicz M, Govi S, Messina C, Porter D, Radford J, Heo DS, Park Y, Martinelli G, Taylor E, Lucraft H, Hong A, Scarfò L, Zucca E, Christie D on behalf of the International Extranodal Lymphoma Study Group (IELSG) |
| Study | IELSG14 |
| |
| Reference | Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the International Extranodal Lymphoma Study Group (the IELSG 14 study). Br J Haematol. 2014 Mar; 164(6): 834-840 Link |
| Author(s) | Messina C, Ferreri AJ, Govi S, Bruno-Ventre M, Gracia Medina EA, Porter D, Radford J, Heo DS, Park HY, Pro B, Jayamohan J, Visco C, Scarfò L, Zucca E, Gospodarowicz M, Christie D; the International Extranodal Lymphoma Study Group (IELSG) |
| Study | IELSG14 |
| |
| Reference | The clinical features, management and prognosis of primary and secondary indolent lymphoma of the bone: a retrospective study of the International Extranodal Lymphoma Study Group (the IELSG #14 study). Leuk Lymphoma. 2014 Aug;55(8):1796-9. doi: 10.3109/10428194.2013.853298. Epub 2014 Feb 4 Link |
| Author(s) | Govi S, Christie D, Mappa S, Marturano E, Bruno Ventre M, Messina C, Gracia Medina EA, Porter D, Radford J, Heo DS, Park Y, Pro B, Jayamohan J, Pavlakis N, Zucca E, Gospodarowicz M, Ferreri AJ on behalf of the International Extranodal Lymphoma Study Group (IELSG) |
| Study | IELSG14 |
| |
| Reference | The clinical features, management and prognostic effects of pathological fractures in a multicenter series of 373 patients with diffuse large B-cell lymphoma of the bone. Annals of Oncology 2014 Jan; 25(1): 176-181 Link |
| Author(s) | Govi S, Christie D, Messina C, Bruno Ventre M, Gracia Medina EA, Porter D, Radford J, Heo DS, Park Y, Martinelli G, Taylor E, Lucraft H, Ballova V, Zucca E, Gospodarowicz M, Ferreri AJ on behalf of the International Extranodal Lymphoma Study Group (IELSG) |
| Study | IELSG14 |
| |
| Reference | Early-stage diffuse large B cell lymphoma of the head and neck: clinico-biological characterization and 18 year follow-up of 488 patients (IELSG 23 study). Annals of Hematology 2014 Jan; 93: 221-231 Link |
| Author(s) | Mian M, Capello D, Ventre MB, Grazio D, Svaldi M, Rossi A, Tsang R, Gospodarowicz MK, Oldani E, Federico M, Luminari S, Marcheselli L, Pogliani EM, Rossini F, Cabrera ME, Martelli M, Gutierrez-Garcia G, Busetto M, Visco C, Fiegl M, Rossi D, Gaidano G, Cavalli F, Zucca E, Rambaldi A, Cortelazzo S; on behalf of the International Extranodal Lymphoma Study Group (IELSG) |
| Study | IELSG23 |
| |
| Reference | Addition of Rituximab to Chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the ielsg-19 randomized study. J Clin Oncol. 2013 Feb 10; 31(5): 565-72 Link PDF (136K) |
| Author(s) | E Zucca, A Conconi, D Laszlo, A López-Guillermo, R Bouabdallah, B Coiffier, C Sebban, F Jardin, U Vitolo, F Morschhauser, SA Pileri, C Copie-Bergman, E Campo, A Jack, I Floriani, P Johnson, M Martelli, F Cavalli, G Martinelli and C Thieblemont |
| Study | IELSG19 |
